D
Sanara MedTech Inc.
SMTI
$31.05
-$0.85-2.67%
D
Sell
11/14/2024Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 11/14/2024 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 245.23% from -$1.41M to $2.05M, earnings per share increased from -$0.4138 to -$0.3355, and EBIT increased 15.61% from -$1.6M to -$1.35M.
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 11/14/2024 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 245.23% from -$1.41M to $2.05M, earnings per share increased from -$0.4138 to -$0.3355, and EBIT increased 15.61% from -$1.6M to -$1.35M.
E
Sell
11/6/2024Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/6/2024 due to a decline in the volatility index and growth index.
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/6/2024 due to a decline in the volatility index and growth index.
D
Sell
10/22/2024Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 10/22/2024 due to an increase in the volatility index and total return index.
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 10/22/2024 due to an increase in the volatility index and total return index.
E
Sell
9/27/2024Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 9/27/2024 due to a decline in the volatility index.
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 9/27/2024 due to a decline in the volatility index.
D
Sell
9/12/2024Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 9/12/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 11.45% from -$1.59M to -$1.41M, total revenue increased 8.75% from $18.54M to $20.16M, and EBIT increased 0.08% from -$1.6M to -$1.6M.
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 9/12/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 11.45% from -$1.59M to -$1.41M, total revenue increased 8.75% from $18.54M to $20.16M, and EBIT increased 0.08% from -$1.6M to -$1.6M.
E
Sell
6/17/2024Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 6/17/2024 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0283 to -$0.2095, operating cash flow declined 87.91% from -$848.5 to -$1.59M, and the quick ratio declined from 0.99 to 0.95.
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 6/17/2024 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0283 to -$0.2095, operating cash flow declined 87.91% from -$848.5 to -$1.59M, and the quick ratio declined from 0.99 to 0.95.
D
Sell
12/18/2023Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 12/18/2023 due to an increase in the volatility index.
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 12/18/2023 due to an increase in the volatility index.
E
Sell
11/29/2023Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/29/2023 due to a decline in the volatility index, total return index and valuation index.
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/29/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
11/14/2023Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 11/14/2023 due to a major increase in the growth index and volatility index. Operating cash flow increased 161.87% from -$1.72M to $1.06M, earnings per share increased from -$0.2222 to -$0.1273, and EBIT increased 28.67% from -$2.23M to -$1.59M.
Sanara MedTech Inc. (SMTI) was upgraded to D- from E+ on 11/14/2023 due to a major increase in the growth index and volatility index. Operating cash flow increased 161.87% from -$1.72M to $1.06M, earnings per share increased from -$0.2222 to -$0.1273, and EBIT increased 28.67% from -$2.23M to -$1.59M.
E
Sell
11/3/2023Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/3/2023 due to a significant decline in the total return index, volatility index and solvency index.
Sanara MedTech Inc. (SMTI) was downgraded to E+ from D- on 11/3/2023 due to a significant decline in the total return index, volatility index and solvency index.
D
Sell
3/14/2023Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 03/14/2023.
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, volatility index and valuation index.
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, volatility index and valuation index.
D
Sell
2/8/2023Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index and valuation index. Earnings per share declined from $0.0987 to -$0.1814, and operating cash flow declined 42.35% from -$1.15M to -$1.64M.
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index and valuation index. Earnings per share declined from $0.0987 to -$0.1814, and operating cash flow declined 42.35% from -$1.15M to -$1.64M.
D
Sell
5/5/2022Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
D
Sell
4/20/2022Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, growth index and solvency index. EBIT declined 84.06% from -$1.85M to -$3.41M, earnings per share declined from -$0.2687 to -$0.4714, and the quick ratio declined from 5.93 to 3.59.
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, growth index and solvency index. EBIT declined 84.06% from -$1.85M to -$3.41M, earnings per share declined from -$0.2687 to -$0.4714, and the quick ratio declined from 5.93 to 3.59.
D
Sell
11/15/2021Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 11/15/2021 due to an increase in the volatility index.
Sanara MedTech Inc. (SMTI) was upgraded to D from D- on 11/15/2021 due to an increase in the volatility index.
D
Sell
11/8/2021Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and valuation index. Total capital declined 2.35% from $35.92M to $35.08M.
Sanara MedTech Inc. (SMTI) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and valuation index. Total capital declined 2.35% from $35.92M to $35.08M.
D
Sell
5/13/2020Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D from D+ on 5/13/2020 due to a substantial decline in the efficiency index, total return index and valuation index. Net income declined 25.56% from -$1.46M to -$1.84M, and total capital declined 16.06% from $8.49M to $7.13M.
Sanara MedTech Inc. (SMTI) was downgraded to D from D+ on 5/13/2020 due to a substantial decline in the efficiency index, total return index and valuation index. Net income declined 25.56% from -$1.46M to -$1.84M, and total capital declined 16.06% from $8.49M to $7.13M.
D
Sell
4/23/2020Downgrade
Sanara MedTech Inc. (SMTI) was downgraded to D+ from C- on 4/23/2020 due to a decline in the total return index, solvency index and volatility index.
Sanara MedTech Inc. (SMTI) was downgraded to D+ from C- on 4/23/2020 due to a decline in the total return index, solvency index and volatility index.
C
Hold
3/27/2020Upgraded
Sanara MedTech Inc. (SMTI) was upgraded to C- from D on 3/27/2020 due to a significant increase in the total return index, efficiency index and solvency index. The quick ratio increased from 0.3 to 3.01, total capital increased 286.97% from $2.19M to $8.49M, and debt to equity declined from -0.27 to -0.34.
Sanara MedTech Inc. (SMTI) was upgraded to C- from D on 3/27/2020 due to a significant increase in the total return index, efficiency index and solvency index. The quick ratio increased from 0.3 to 3.01, total capital increased 286.97% from $2.19M to $8.49M, and debt to equity declined from -0.27 to -0.34.
D
Sell
5/21/2019Upgraded
Sanara MedTech Inc. (WNDMD) was upgraded to D from D- on 5/21/2019 due to a noticeable increase in the valuation index, growth index and volatility index. Total revenue increased 5,135.58% from $47.5 to $2.49M, and EBIT increased 66.4% from -$467.6 to -$157.1.
Sanara MedTech Inc. (WNDMD) was upgraded to D from D- on 5/21/2019 due to a noticeable increase in the valuation index, growth index and volatility index. Total revenue increased 5,135.58% from $47.5 to $2.49M, and EBIT increased 66.4% from -$467.6 to -$157.1.
D
Sell
5/15/2019Downgrade
Sanara MedTech Inc. (WNDMD) was downgraded to D- from D on 5/15/2019 due to a decline in the growth index, valuation index and efficiency index. EBIT declined 254.24% from -$132 to -$467.6, earnings per share declined from -$0.0006 to -$0.0021, and net income declined 222.45% from -$151 to -$486.9.
Sanara MedTech Inc. (WNDMD) was downgraded to D- from D on 5/15/2019 due to a decline in the growth index, valuation index and efficiency index. EBIT declined 254.24% from -$132 to -$467.6, earnings per share declined from -$0.0006 to -$0.0021, and net income declined 222.45% from -$151 to -$486.9.
D
Sell
3/12/2019Upgraded
WNDM Medical Inc. (WNDM) was upgraded to D from D- on 3/12/2019 due to an increase in the volatility index and total return index.
WNDM Medical Inc. (WNDM) was upgraded to D from D- on 3/12/2019 due to an increase in the volatility index and total return index.
D
Sell
1/8/2019Downgrade
WNDM Medical Inc. (WNDM) was downgraded to D- from D on 1/8/2019 due to a large decline in the total return index, volatility index and efficiency index. Net income declined 583.97% from $31.2 to -$151.
WNDM Medical Inc. (WNDM) was downgraded to D- from D on 1/8/2019 due to a large decline in the total return index, volatility index and efficiency index. Net income declined 583.97% from $31.2 to -$151.
D
Sell
8/14/2018Downgrade
WNDM Medical Inc. (WNDM) was downgraded to D from D+ on 8/14/2018 due to a major decline in the growth index, efficiency index and total return index. EBIT declined 53.52% from $66.7 to $31.
WNDM Medical Inc. (WNDM) was downgraded to D from D+ on 8/14/2018 due to a major decline in the growth index, efficiency index and total return index. EBIT declined 53.52% from $66.7 to $31.
D
Sell
7/24/2018Upgraded
WNDM Medical Inc. (WNDM) was upgraded to D+ from D on 7/24/2018 due to a noticeable increase in the growth index, solvency index and efficiency index. The quick ratio increased from 0.61 to 2.77, EBIT increased 339.93% from -$27.8 to $66.7, and total capital increased 30.08% from $1.3M to $1.69M.
WNDM Medical Inc. (WNDM) was upgraded to D+ from D on 7/24/2018 due to a noticeable increase in the growth index, solvency index and efficiency index. The quick ratio increased from 0.61 to 2.77, EBIT increased 339.93% from -$27.8 to $66.7, and total capital increased 30.08% from $1.3M to $1.69M.
D
Sell
4/2/2018Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D from C- on 4/2/2018 due to a major decline in the valuation index, growth index and solvency index.
Wound Management Technologies, Inc. (WNDM) was downgraded to D from C- on 4/2/2018 due to a major decline in the valuation index, growth index and solvency index.
C
Hold
3/15/2018Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 3/15/2018 due to an increase in the volatility index, valuation index and total return index.
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 3/15/2018 due to an increase in the volatility index, valuation index and total return index.
D
Sell
1/11/2018Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to D+ from D on 1/11/2018 due to an increase in the total return index and volatility index.
Wound Management Technologies, Inc. (WNDM) was upgraded to D+ from D on 1/11/2018 due to an increase in the total return index and volatility index.
D
Sell
12/27/2017Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D from D+ on 12/27/2017 due to a decline in the total return index and volatility index.
Wound Management Technologies, Inc. (WNDM) was downgraded to D from D+ on 12/27/2017 due to a decline in the total return index and volatility index.
D
Sell
11/17/2017Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C on 11/17/2017 due to a significant decline in the efficiency index, valuation index and growth index. Operating cash flow declined 733.84% from $46.4 to -$294.1, earnings per share declined from $0.0003 to -$0.0008, and net income declined 161.52% from $79 to -$48.6.
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C on 11/17/2017 due to a significant decline in the efficiency index, valuation index and growth index. Operating cash flow declined 733.84% from $46.4 to -$294.1, earnings per share declined from $0.0003 to -$0.0008, and net income declined 161.52% from $79 to -$48.6.
C
Hold
8/16/2017Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C from D on 8/16/2017 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 128.33% from -$163.8 to $46.4, EBIT increased 103.6% from $58.3 to $118.7, and earnings per share increased from $0.0002 to $0.0003.
Wound Management Technologies, Inc. (WNDM) was upgraded to C from D on 8/16/2017 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 128.33% from -$163.8 to $46.4, EBIT increased 103.6% from $58.3 to $118.7, and earnings per share increased from $0.0002 to $0.0003.
D
Sell
5/17/2017Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D from C on 5/17/2017 due to a substantial decline in the efficiency index and growth index. Operating cash flow declined 139.07% from $419.3 to -$163.8, earnings per share declined from $0.0017 to $0.0002, and EBIT declined 78.93% from $276.7 to $58.3.
Wound Management Technologies, Inc. (WNDM) was downgraded to D from C on 5/17/2017 due to a substantial decline in the efficiency index and growth index. Operating cash flow declined 139.07% from $419.3 to -$163.8, earnings per share declined from $0.0017 to $0.0002, and EBIT declined 78.93% from $276.7 to $58.3.
C
Hold
4/17/2017Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 4/17/2017 due to a noticeable increase in the growth index and total return index.
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 4/17/2017 due to a noticeable increase in the growth index and total return index.
C
Hold
4/5/2017Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D- on 4/5/2017 due to a significant increase in the efficiency index, total return index and solvency index. The quick ratio increased from 0.79 to 1.17, net income increased 29.42% from $181.5 to $234.9, and total capital increased 26.25% from $946.5 to $1.2M.
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D- on 4/5/2017 due to a significant increase in the efficiency index, total return index and solvency index. The quick ratio increased from 0.79 to 1.17, net income increased 29.42% from $181.5 to $234.9, and total capital increased 26.25% from $946.5 to $1.2M.
D
Sell
5/18/2016Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D- from D on 5/18/2016 due to a noticeable decline in the total return index, efficiency index and valuation index.
Wound Management Technologies, Inc. (WNDM) was downgraded to D- from D on 5/18/2016 due to a noticeable decline in the total return index, efficiency index and valuation index.
D
Sell
4/15/2016Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D from D+ on 4/15/2016 due to a substantial decline in the growth index and total return index. Earnings per share declined from -$0.0023 to -$0.0098, EBIT declined 198.64% from -$131.9 to -$393.9, and total revenue declined 21.88% from $905.6 to $707.5.
Wound Management Technologies, Inc. (WNDM) was downgraded to D from D+ on 4/15/2016 due to a substantial decline in the growth index and total return index. Earnings per share declined from -$0.0023 to -$0.0098, EBIT declined 198.64% from -$131.9 to -$393.9, and total revenue declined 21.88% from $905.6 to $707.5.
D
Sell
3/11/2016Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 3/11/2016 due to a major decline in the volatility index.
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 3/11/2016 due to a major decline in the volatility index.
C
Hold
11/13/2015Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 11/13/2015 due to a major increase in the growth index and solvency index. Total revenue increased 21.54% from $745.1 to $905.6, and debt to equity declined from -1.02 to -1.01.
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 11/13/2015 due to a major increase in the growth index and solvency index. Total revenue increased 21.54% from $745.1 to $905.6, and debt to equity declined from -1.02 to -1.01.
D
Sell
10/12/2015Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 10/12/2015 due to a large decline in the volatility index, growth index and solvency index. Total revenue declined 26.52% from $1.01M to $745.1, and debt to equity increased from -0.98 to -1.02.
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 10/12/2015 due to a large decline in the volatility index, growth index and solvency index. Total revenue declined 26.52% from $1.01M to $745.1, and debt to equity increased from -0.98 to -1.02.
C
Hold
4/27/2015Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 4/27/2015 due to a noticeable increase in the volatility index, growth index and solvency index. Debt to equity declined from -1.12 to -0.97, operating cash flow increased 10.31% from -$283.2 to -$312.4, and total revenue increased 7.04% from $679.1 to $726.9.
Wound Management Technologies, Inc. (WNDM) was upgraded to C- from D+ on 4/27/2015 due to a noticeable increase in the volatility index, growth index and solvency index. Debt to equity declined from -1.12 to -0.97, operating cash flow increased 10.31% from -$283.2 to -$312.4, and total revenue increased 7.04% from $679.1 to $726.9.
D
Sell
6/3/2014Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 6/3/2014 due to a substantial decline in the volatility index.
Wound Management Technologies, Inc. (WNDM) was downgraded to D+ from C- on 6/3/2014 due to a substantial decline in the volatility index.
C
Hold
5/16/2014Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to C- from C on 5/16/2014 due to a significant decline in the efficiency index. Total capital declined 358.7% from -$768 to $1.99M, and net income declined 63.25% from -$1.49M to -$546.
Wound Management Technologies, Inc. (WNDM) was downgraded to C- from C on 5/16/2014 due to a significant decline in the efficiency index. Total capital declined 358.7% from -$768 to $1.99M, and net income declined 63.25% from -$1.49M to -$546.
C
Hold
4/15/2014Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 4/15/2014 due to a significant increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 0.04 to 0.08.
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 4/15/2014 due to a significant increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 0.04 to 0.08.
C
Hold
4/11/2014Downgrade
Wound Management Technologies, Inc. (WNDM) was downgraded to C- from C on 4/11/2014 due to a decline in the total return index.
Wound Management Technologies, Inc. (WNDM) was downgraded to C- from C on 4/11/2014 due to a decline in the total return index.
C
Hold
3/6/2014Upgraded
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 3/6/2014 due to a large increase in the volatility index, valuation index and growth index.
Wound Management Technologies, Inc. (WNDM) was upgraded to C from C- on 3/6/2014 due to a large increase in the volatility index, valuation index and growth index.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
